These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 363332)
1. Clinical pharmacokinetics of hypolipidaemic drugs. Gugler R Clin Pharmacokinet; 1978; 3(6):425-39. PubMed ID: 363332 [No Abstract] [Full Text] [Related]
2. The effect of hypolipidemic drugs on plasma lipoproteins. Levy RI Annu Rev Pharmacol Toxicol; 1977; 17():499-510. PubMed ID: 326171 [No Abstract] [Full Text] [Related]
3. Disposition, metabolism and pharmacokinetics of antihyperlipidemic agents in laboratory animals and man. Cayen MN Pharmacol Ther; 1985; 29(2):157-204. PubMed ID: 3915091 [No Abstract] [Full Text] [Related]
4. Lack of pharmacokinetic interaction between cholestyramine and acipimox, a new lipid lowering drug. de Paolis C; Farina R; Pianezzola E; Valzelli G; Celotti F; Pontiroli AE Br J Clin Pharmacol; 1986 Oct; 22(4):496-7. PubMed ID: 3533131 [No Abstract] [Full Text] [Related]
9. [Lowering lipids rapidly and permanently with etofibrate]. von Bock und Polach U Med Klin; 1982 Jan; 77(3):35-8. PubMed ID: 7057729 [No Abstract] [Full Text] [Related]
10. Hypolipidemic drugs. Fleischmajer R Am Fam Physician; 1978 Feb; 17(2):188-90. PubMed ID: 622945 [No Abstract] [Full Text] [Related]
11. Pharmacokinetics and hypolipidemic activity of clofibrate-nicotinic acid combinations in rats. Cayen MN; Robinson WT; Dubuc J; Dvornik D Biochem Pharmacol; 1979 Apr; 28(7):1163-7. PubMed ID: 444274 [No Abstract] [Full Text] [Related]
13. [Indications for surgical treatment and medical treatment of atherosclerosis]. Paredero Del Bosque Martin V Minerva Med; 1980 Oct; 71(40):2963-7. PubMed ID: 7454082 [No Abstract] [Full Text] [Related]
14. Lack of effect of cholestyramine on the pharmacokinetics of clofibrate in man. Sedaghat A; Ahrens EH Eur J Clin Invest; 1975 Apr; 5(2):177-85. PubMed ID: 1149779 [TBL] [Abstract][Full Text] [Related]
15. Drug interactions and side effects of hypolipidemic drugs. Schwandt P Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):351-6. PubMed ID: 489202 [TBL] [Abstract][Full Text] [Related]